The following highlights spotlight the latest research in rheumatology, featuring studies presented at this year’s annual European Alliance of Associations for Rheumatology (EULAR) 2024 Congress.
AB1693-PARE THE EVOLVING ROLE OF PATIENTS AS AUTHORS AT THE ANNUAL EUROPEAN CONGRESS OF RHEUMATOLOGY
Background: An increasing number of congresses are encouraging patients (inclusive of caregivers and patient organisation representatives) to present and publish research [1]. The European Alliance of ...
– RESET-RA is the first randomized, sham-controlled, double-blind trial to positively demonstrate the clinical potential of neuroimmune modulation for the treatment of rheumatoid arthritis (RA) – – ...
The School of Infection & Immunity's Dr Eve Smith recently received the prestigious EULAR Abstract Award – FOREUM: Clinical Science at this year’s EULAR 2025 Congress. The world’s largest rheumatology ...
Andrew Cope | Panel member for Basic and Translational Science at EULAR; Head of the Centre for Rheumatic Diseases and Associate Director of the King’s Clinical Trials Unit, King’s College London, UK ...
This flagship event brings together the world’s leading experts in rheumatology to discuss groundbreaking research, clinical innovations, and advancements in patient care. EULAR 2024 Congress will ...
BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969), a leading biotech company, announced today that Professor Zhanguo Li, the leading PI, has presented latest data of BTK inhibitor orelabrutinib ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results